The New York State Psychiatric Institute, located at the Columbia University Irving Medical Center in the Washington Heights neighborhood of Manhattan, New York City, was established in 1895 as one of ...

During the past decade, Columbia University/New York State Psychiatric Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University/New York State Psychiatric Institute" #1 collaborator was "National Institute of Mental Health (NIMH)" with 8 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator, "American Foundation for Suicide Prevention" with 1 trials as a collaborator and "Brain & Behavior Research Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University/New York State Psychiatric Institute" are "Depression" (5 trials), "Suicidal Ideation" (3 trials), "Heroin Dependence" (2 trials), "Major Depressive Disorder" (2 trials) and "Opioid-Related Disorders" (2 trials). Many other conditions were trialed in "Columbia University/New York State Psychiatric Institute" in a lesser frequency.

Most popular intervention types in "Columbia University/New York State Psychiatric Institute" are "Drug" (8 trials), "Behavioral" (4 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine" (2 trials), "Ketamine" (2 trials), "Midazolam" (2 trials), "Standard Psychiatric Treatment" (2 trials) and "Active dTMS Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University/New York State Psychiatric Institute" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University/New York State Psychiatric Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Columbia University/New York State Psychiatric Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University/New York State Psychiatric Institute, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".